Skip to main content

Clinical Experiences with the Use of Indole-3-Pyruvic Acid

  • Chapter
Tryptophan, Serotonin, and Melatonin

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 467))

Abstract

In the last few years, Indol-3-pyruvic acid (IPA) has been subjected to 5 pilot clinical trials in volunteers and a phase II study on patients affected by anxiety, with or without sleep problems. Overall, results indicated a very good safety profile, relief from anxiety and a better quality of sleep in patients treated with IPA. Moreover, the drug showed no withdrawal signs, but positive effects on mood, improving feelings of relaxation, calmness and happiness. The mechanism of action of IPA, depending on increased turnover of some indoles in the CNS, appears clearly distinct from that of benzodiazepines, suggesting that the drug might be used in the treatment of symptoms of mild anxiety and stress experienced by busy and anxious people.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bacciottini L., Pellegrini-Giampietro D.E., Bongianni F., De Luca G., Beni M, Politi V., and Moroni F., 1987, Biochemical and behavioural studies on indole-pyruvic acid: a keto-analogue of tryptophan, Pharmacol. Res. Communic. 19:803–817.

    Article  CAS  Google Scholar 

  • Biagini G., Merlo-Pich E., Carani C., Marrama P., Gustafsson J.A., Fuxe K,, and Agnati L.F., 1993, Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression, Biol. Psych. 33:712–719.

    Article  CAS  Google Scholar 

  • Bruno V., Canonico P.L., Aronica E., Nicoletti F., and Scapagnini U., 1991, Modulation of excitatory amino acid receptors by indolpyruvic acid, Neurosci. Res. Commun. 8:137–145.

    CAS  Google Scholar 

  • Ferretti C., Blengio M., Ghi P., and Genazzani E., 1990, Differential effects of indolepyruvic acid and 5-hydrox-ytryptophan on indole metabolism in the pineal gland of the rat during the light-dark cycle, Eur. J. Pharmacol. 187:345–356.

    Article  PubMed  CAS  Google Scholar 

  • Lavaggi M.V., Politi V., De Luca G., and Gorini A., 1987, Effects of Indol-3-ylpyruvic acid on Tryptophan pyrrolase activity “in vitro” and “in vivo”, in: Progress in Tryptophan and Serotonin Research 1986 (H.G. Schlossberger et al. eds.), pp. 51–54, De Gruyter and Co., Berlin.

    Google Scholar 

  • Politi V., D’Alessio S., Di Stazio G., and De Luca G., 1996, Antioxidant properties of Indol-3-ylpyruvic acid, in: Recent Advances in Tryptophan Research (G. Allegri Filippini et al. eds.), pp. 291–298, Plenum Press, New York.

    Chapter  Google Scholar 

  • Politi V., Lavaggi M.V., Di Stazio G., and Margonelli A., 1991, Indol-3-ylpyruvic acid as a direct precursor of kynurenic acid, Adv. Exptl. Med. Biol. 294:515–518.

    Article  CAS  Google Scholar 

  • Ruggieri M., Merlo-Pich E., Zini I., Fuxe K., and Agnati L.F., 1990, Indole-pyruvic acid increases 5-hydrox-yindoleacetic acid levels in the cerebrospinal fluid and fronto-parietal cortex of the rat. A microdyaly-sis study, Acta Physiol. Scand. 138:97–98.

    Article  Google Scholar 

  • Russi P., Carlà V., and Moroni F., 1989, Indolpyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo? Biochem. Pharmacol. 38:2405–2409.

    Article  PubMed  CAS  Google Scholar 

  • Shamsi Z., Stanley N., Yoon J., and Hindmarch I., 1996, Effects of three doses of 3-indole pyruvic acid on subjective and objective measures of sleep and early morning performance. Human Psychopharmacol. 11:235–239.

    Article  CAS  Google Scholar 

  • Silvestri R., Mento G., Raffaele M., De Luca G., Buttini G., Casella C., Tisano A., De Domenico P, Di Rosa A.E., and Di Perri R., 1991, Indol-3-ylpyruvic acid as a possible hypnotic agent in insomniac subjects, J. Intl. Med. Res. 19:403–409.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Politi, V., De Luca, G., Gallai, V., Puca, Comin, M. (1999). Clinical Experiences with the Use of Indole-3-Pyruvic Acid. In: Huether, G., Kochen, W., Simat, T.J., Steinhart, H. (eds) Tryptophan, Serotonin, and Melatonin. Advances in Experimental Medicine and Biology, vol 467. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4709-9_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4709-9_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7133-5

  • Online ISBN: 978-1-4615-4709-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics